A Study of Erlotinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations
Clinical trial NCT01260181 · COMPLETED
Trial details
- NCT number
- NCT01260181
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-31
- Primary completion
- 2017-09-29
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.